ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members. Disclaimer ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||
Pfizer's once-daily Lyrica met goal of trial in FibromyalgiaWednesday 21 November 2012
Pfizer's once-daily Lyrica met goal of trial in fibromyalgia (Reuters) - Pfizer Inc said on Monday a late-stage trial of a once-daily version of its drug Lyrica in patients with fibromyalgia, a pain condition affecting more than 5 million Americans, met its main goal. Patients taking once-daily Lyrica, also known as pregabalin, went for a significantly longer period of time before feeling pain compared with patients who took a placebo. The study is the second of three late-stage trials testing a controlled-release version of the drug, which is currently given several times a day. A trial of the controlled-release version of the drug in patients with certain types of seizures did not meet its main goal, Pfizer said. The company is also studying the drug in patients with neuralgia.
The above originally appeared here.
blog comments powered by Disqus |
||||||||||||
|
Registered Charity 3104
Email:
sacfs@sacfs.asn.au
Mailing address:
PO Box 322,
Modbury North,
South Australia 5092
Phone:
1300 128 339
Office Hours:
Monday - Friday,
10am - 4pm
(phone)